Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (Jul 2018)
Endothelial Dysfunction, Increased Arterial Stiffness, and Cardiovascular Risk Prediction in Patients With Coronary Artery Disease: FMD‐J (Flow‐Mediated Dilation Japan) Study A
- Tatsuya Maruhashi,
- Junko Soga,
- Noritaka Fujimura,
- Naomi Idei,
- Shinsuke Mikami,
- Yumiko Iwamoto,
- Akimichi Iwamoto,
- Masato Kajikawa,
- Takeshi Matsumoto,
- Nozomu Oda,
- Shinji Kishimoto,
- Shogo Matsui,
- Haruki Hashimoto,
- Yoshiki Aibara,
- Farina Mohamad Yusoff,
- Takayuki Hidaka,
- Yasuki Kihara,
- Kazuaki Chayama,
- Kensuke Noma,
- Ayumu Nakashima,
- Chikara Goto,
- Hirofumi Tomiyama,
- Bonpei Takase,
- Takahide Kohro,
- Toru Suzuki,
- Tomoko Ishizu,
- Shinichiro Ueda,
- Tsutomu Yamazaki,
- Tomoo Furumoto,
- Kazuomi Kario,
- Teruo Inoue,
- Shinji Koba,
- Kentaro Watanabe,
- Yasuhiko Takemoto,
- Takuzo Hano,
- Masataka Sata,
- Yutaka Ishibashi,
- Koichi Node,
- Koji Maemura,
- Yusuke Ohya,
- Taiji Furukawa,
- Hiroshi Ito,
- Hisao Ikeda,
- Akira Yamashina,
- Yukihito Higashi
Affiliations
- Tatsuya Maruhashi
- Department of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
- Junko Soga
- Department of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
- Noritaka Fujimura
- Department of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
- Naomi Idei
- Department of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
- Shinsuke Mikami
- Department of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
- Yumiko Iwamoto
- Department of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
- Akimichi Iwamoto
- Department of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
- Masato Kajikawa
- Department of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
- Takeshi Matsumoto
- Department of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
- Nozomu Oda
- Department of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
- Shinji Kishimoto
- Department of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
- Shogo Matsui
- Department of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
- Haruki Hashimoto
- Department of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
- Yoshiki Aibara
- Department of Cardiovascular Regeneration and Medicine Research Institute for Radiation Biology and Medicine Hiroshima University Hiroshima Japan
- Farina Mohamad Yusoff
- Department of Cardiovascular Regeneration and Medicine Research Institute for Radiation Biology and Medicine Hiroshima University Hiroshima Japan
- Takayuki Hidaka
- Department of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
- Yasuki Kihara
- Department of Cardiovascular Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
- Kazuaki Chayama
- Department of Gastroenterology and Metabolism Biomedical Sciences Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
- Kensuke Noma
- Department of Cardiovascular Regeneration and Medicine Research Institute for Radiation Biology and Medicine Hiroshima University Hiroshima Japan
- Ayumu Nakashima
- Division of Regeneration and Medicine Hiroshima University Hospital Hiroshima Japan
- Chikara Goto
- Hiroshima International University Hiroshima Japan
- Hirofumi Tomiyama
- Department of Cardiology Tokyo Medical University Tokyo Japan
- Bonpei Takase
- Division of Biomedical Engineering National Defense Medical College Research Institute Tokorozawa Japan
- Takahide Kohro
- Department of Cardiology Tokyo Medical University Tokyo Japan
- Toru Suzuki
- Cardiovascular Medicine University of Leicester United Kingdom
- Tomoko Ishizu
- Cardiovascular Division Institute of Clinical Medicine University of Tsukuba Ibaraki Japan
- Shinichiro Ueda
- Department of Clinical Pharmacology and Therapeutics University of the Ryukyu School of Medicine Okinawa Japan
- Tsutomu Yamazaki
- Clinical Research Support Center Faculty of Medicine The University of Tokyo Japan
- Tomoo Furumoto
- Department of Cardiovascular Medicine Hokkaido University Graduate School of Medicine Hokkaido Japan
- Kazuomi Kario
- Division of Cardiovascular Medicine Jichi Medical University School of Medicine Tochigi Japan
- Teruo Inoue
- Department of Cardiovascular Medicine Dokkyo Medical University Mibu Tochigi Japan
- Shinji Koba
- Department of Medicine Division of Cardiology Showa University School of Medicine Tokyo Japan
- Kentaro Watanabe
- Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology (DNHMED) Yamagata University School of Medicine Yamagata Japan
- Yasuhiko Takemoto
- Department of Internal Medicine and Cardiology Osaka City University Graduate School of Medicine Osaka Japan
- Takuzo Hano
- Department of Medical Education and Population‐Based Medicine Postgraduate School of Medicine Wakayama Medical University Wakayama Japan
- Masataka Sata
- Department of Cardiovascular Medicine Institute of Health Biosciences The University of Tokushima Graduate School Tokushima Japan
- Yutaka Ishibashi
- Department of General Medicine Shimane University Faculty of Medicine Izumo Japan
- Koichi Node
- Department of Cardiovascular and Renal Medicine Saga University Saga Japan
- Koji Maemura
- Department of Cardiovascular Medicine Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan
- Yusuke Ohya
- The Third Department of Internal Medicine University of the Ryukyus Okinawa Japan
- Taiji Furukawa
- Department of Internal Medicine Teikyo University School of Medicine Tokyo Japan
- Hiroshi Ito
- Department of Cardiovascular Medicine Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan
- Hisao Ikeda
- Faculty of Fukuoka Medical Technology Teikyo University Omuta Japan
- Akira Yamashina
- Department of Cardiology Tokyo Medical University Tokyo Japan
- Yukihito Higashi
- Department of Cardiovascular Regeneration and Medicine Research Institute for Radiation Biology and Medicine Hiroshima University Hiroshima Japan
- DOI
- https://doi.org/10.1161/JAHA.118.008588
- Journal volume & issue
-
Vol. 7,
no. 14
Abstract
Background The usefulness of vascular function tests for management of patients with a history of coronary artery disease is not fully known. Methods and Results We measured flow‐mediated vasodilation (FMD) and brachial–ankle pulse wave velocity (baPWV) in 462 patients with coronary artery disease for assessment of the predictive value of FMD and baPWV for future cardiovascular events in a prospective multicenter observational study. The first primary outcome was coronary events, and the second primary outcome was a composite of coronary events, stroke, heart failure, and sudden death. During a median follow‐up period of 49.2 months, the first primary outcome occurred in 56 patients and the second primary outcome occurred in 66 patients. FMD above the cutoff value of 7.1%, derived from receiver‐operator curve analyses for the first and second primary outcomes, was significantly associated with lower risk of the first (hazard ratio, 0.27; 95% confidence interval, 0.06–0.74; P=0.008) and second (hazard ratio, 0.32; 95% confidence interval, 0.09–0.79; P=0.01) primary outcomes. baPWV above the cutoff value of 1731 cm/s was significantly associated with higher risk of the first (hazard ratio, 1.86; 95% confidence interval, 1.01–3.44; P=0.04) and second (hazard ratio, 2.19; 95% confidence interval, 1.23–3.90; P=0.008) primary outcomes. Among 4 groups stratified according to the combination of cutoff values of FMD and baPWV, stepwise increases in the calculated risk ratio for the first and second primary outcomes were observed. Conclusions In patients with coronary artery disease, both FMD and baPWV were significant predictors of cardiovascular events. The combination of FMD and baPWV provided further cardiovascular risk stratification. Clinical Trial Registration URL: www.umin.ac.jp. Unique identifier: UMIN000012950.
Keywords
- arterial stiffness
- coronary artery disease
- endothelial function
- flow‐induced dilation
- pulse wave velocity